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 Obesity-dependent changes in interstitial ECM
mechanics promote breast tumorigenesis
Bo Ri Seo,1 Priya Bhardwaj,2 Siyoung Choi,1 Jacqueline Gonzalez,1 Roberto C. Andresen Eguiluz,3
Karin Wang,1,3 Sunish Mohanan,4 Patrick G. Morris,5 Baoheng Du,2 Xi K. Zhou,6 Linda T. Vahdat,2
Akanksha Verma,7 Olivier Elemento,7 Clifford A. Hudis,5 Rebecca M. Williams,1
Delphine Gourdon,3 Andrew J. Dannenberg,2 Claudia Fischbach1,8*
Obesity and extracellular matrix (ECM) density are considered independent risk and prognostic factors for breast
cancer. Whether they are functionally linked is uncertain. We investigated the hypothesis that obesity enhances local
myofibroblast content in mammary adipose tissue and that these stromal changes increase malignant potential by
enhancing interstitial ECM stiffness. Indeed, mammary fat of both diet- and genetically induced mouse models of
obesity were enriched for myofibroblasts and stiffness-promoting ECM components. These differences were related
to varied adipose stromal cell (ASC) characteristics because ASCs isolated from obesemice containedmoremyofibro-
blasts and deposited denser and stiffer ECMs relative to ASCs from lean control mice. Accordingly, decellularized
matrices from obese ASCs stimulated mechanosignaling and thereby the malignant potential of breast cancer cells.
Finally, the clinical relevance and translational potential of our findings were supported by analysis of patient speci-
mens and the observation that caloric restriction in a mouse model reduces myofibroblast content in mammary fat.
Collectively, these findings suggest that obesity-induced interstitial fibrosis promotes breast tumorigenesis by
altering mammary ECM mechanics with important potential implications for anticancer therapies./st
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Obesity, with increasing worldwide prevalence, is a key risk factor for
the development and prognosis of breast cancer (1). This correlation
has been commonly attributed to obesity-mediated differences in adi-
pose endocrine functions (2). However, given the critical role of contex-
tual cues in tumorigenesis, obesity-mediated alterations to the local
microenvironment may also be important. In particular, obesity in-
duces fibrotic remodeling of adipose tissue (3), and these changes have
been associated with malignant potential (4). Nevertheless, the exact
mechanisms through which interstitial fibrosis in obese adipose tissue
may affect the pathogenesis of breast cancer remain largely elusive.
Similar toobesity, tumorsalso feature fibrosis in the surrounding stroma,
which is commonly referred to as desmoplasia. The concomitant changes in
extracellularmatrix (ECM)density and rigidity not only enable detectionby
mammography and palpation, respectively, but also represent important
risk factors for tumor development, progression, and response to therapy
(5, 6). More specifically, enhanced stiffness changes cellular mechano-
signaling (7), which, in turn, stimulates more aggressive behavior in
cancer cells through variousmechanisms including perturbed epithelial
morphogenesis (8), growth factor and cytokine signaling (9), and stem
cell differentiation (10, 11). However, whether obesity-associated fibrot-
ic remodeling alters local ECM mechanical properties and whether
these differences activate protumorigenicmechanotransduction remain
to be elucidated.1Departmentof Biomedical Engineering, Cornell University, Ithaca, NY14853,USA. 2Department
of Medicine, Weill Cornell Medical College, New York, NY 10065, USA. 3Department of Materials
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and Biomedical Sciences, Cornell University, Ithaca, NY 14853, USA. 5Department of Medicine,
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www.SciencMyofibroblasts are major cellular regulators of fibrotic and desmo-
plastic remodeling and, thus, tissue mechanical properties (12). Myofi-
broblasts are highly contractile and assemble a fibronectin- and collagen
type I–rich ECM that is characterized by enhanced density, fibrillar
architecture, cross-linking, and partial unfolding—all parameters causally
linked to increased ECM stiffness (11–13). Various proinflammatory cyto-
kines enhanced during obesity [for example, transforming growth factor–b1
(TGF-b1) (14)] can initiatemyofibroblast differentiation inmesenchymal
cells, including adipose stemcells (ASCs) (11).Nevertheless, the impact of
obesity onmyofibroblast content of mammary adipose tissue remains un-
certain as most previous studies were performed with subcutaneous and
visceral fat. Extrapolationof such results tomammary fat shouldbeavoided
because both global functions (15) and fibrotic remodeling (16) of adipose
tissue can vary significantly between anatomic depots.
Here, our goal was to characterize the role of obesity in interstitial
fibrosis in mammary fat, determine the impact of these variations on
ECMmechanical properties, and assess whether these changes enhance
myofibroblast content and the malignant potential of mammary tumor
cells due to altered mechanotransduction. We have applied a multi-
disciplinary approach that integrates biological and physical techniques
to mouse and human samples, ultimately extending our quantitative
understanding of the functional relationship between obesity-induced
alterations in ECM mechanics as it pertains to enhanced breast carci-
nogenesis. Consequently, the risk and prognosis of breast cancer pa-
tients may be more accurately predicted, and therapeutic interference
with the suggested relationship may improve patients’ outcomes.RESULTS
Obesity increases interstitial fibrosis in mouse mammary
fat pads
To quantify fibrotic remodeling, we assessedmyofibroblast content and
related ECM changes in mammary adipose tissue harvested from twoeTranslationalMedicine.org 19 August 2015 Vol 7 Issue 301 301ra130 1
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nestablishedmousemodels of obesity. Diet-induced obesity was achieved
by feeding a high-fat diet to female C57BL/6Jmice for 10 weeks start-
ing at 5 weeks of age (Fig. 1A). Obesity was reflected by increased
weight of these mice relative to lean control animals fed a low-fat diet
(29.7 ± 4.2 g versus 21.2 ± 0.6 g; mean ± SD, n = 20 per group). Addi-
tionally, we used female ob/ob mice, which are morbidly obese com-
pared to age-matched wild-type mice (54.4 ± 2.9 g versus 19.8 ± 1.5 g;
mean ± SD, n = 10 per group) (Fig. 1A) owing to a loss-of-functionmu-
tation in the gene encoding the satiety hormone leptin (17). Histological
evaluation of hematoxylin and eosin (H&E)–stained sections showed
global differences of obese versus lean breast adipose tissue, including
larger adipocytes (Fig. 1B). Additionally, immunofluorescence analysis
suggested that both diet- and genetically induced obesity enhanced levels
of interstitiala–smoothmuscle actin (a-SMA), amyofibroblastmarker,
relative to the respective controls (Fig. 1C). This was further confirmed
by Western blot analysis of mammary adipose tissue from diet-induced
mousemodels. The levels of fibronectin, an ECM component primarilywww.Sciencdeposited by myofibroblasts (12), were also enhanced in obese animals
(Fig. 1D).
High-fat diet increaseda-SMA and fibronectin content in themam-
mary adipose tissue of both ovary-intact mice and ovariectomizedmice
(fig. S1,A toC).Thesedata suggest that theprofibrotic changes aftermeno-
pause are relevant to postmenopausal breast cancer, which is where the
link between obesity and risk of breast cancer is clearest (18). Ovariec-
tomy did not further stimulate a-SMA in response to high-fat diet rela-
tive to intact animals (P = 0.97, Student’s t test), although ovariectomy
with high-fat diet increased mouse weight compared with high-fat diet
alone [24.4 ± 2.8 g (ovariectomy/low-fat diet); 38.9 ± 2.9 g (ovariectomy/
high-fat diet); 29.74 ± 4.15 g (high-fat diet); mean ± SD, n = 20 per group].
Although this increase in weight is accompanied by elevated mammary
gland inflammation (19), our results imply that inflammation may not
be the sole regulator of obesity-induced fibrosis.
In addition to fibrosis, tissues were analyzed for the effect of obesity
on ECM structure. Second harmonic generation (SHG) imaging was at UC M
ERCED on April 28, 2020
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 Fig. 1. Obesity increases interstitial fibrosis inmousemammary fat pads.
(A) Schematic showing the dietary [high-fat diet (HFD) and low-fat diet (LFD),
bars, 200 mm. Western blot quantification is relative to the corresponding
HSP90 levels. (E) SHG imaging of collagen fiber linearity in mammary fat.15 weeks] and genetic [ob/ob and wild-type (WT), 11 weeks] mouse models
of obesity that were used to compare fibrotic remodeling between lean and
obese mammary fat. (B) H&E-stained sections of mammary fat from lean and
obese mice. Scale bars, 200 mm. (C and D) Immunofluorescence and Western
blot analysis of a-SMA (C) and fibronectin (Fn) (D) in mammary fat. ScaleBox plots show medians with whiskers from minimum to maximum values.
Scale bars, 100 mm. (C to E) Data are means ± SD (n = 6 to 11 per group).
*P < 0.05, **P < 0.01, unless otherwise noted, by unpaired Student’s two-
tailed t tests for two conditions and one-way analysis of variance (ANOVA)
for multiple comparisons. DAPI, 4′,6-diamidino-2-phenylindole.eTranslationalMedicine.org 19 August 2015 Vol 7 Issue 301 301ra130 2
R E S EARCH ART I C L Eused to quantify ECM structural changes. Interstitial collagen wasmore
linearized inmammary adipose tissue of obese animals in both diet- and
genetically induced obesitymodels (Fig. 1E). Thus, obesity caused struc-
tural changes of collagen that have been previously associated with
ASC-mediated ECM remodeling, enhanced stiffness, and tumormalig-
nancy in mice and humans (11, 13, 20). In summary, obesity initiates
fibrotic remodeling ofmammary adipose tissue by triggeringmolecular,
cellular, and ECM structural changes.
Obesity enhances the profibrotic phenotype of ASCs
To investigate cellular and molecular differences in obese and lean
animals, we compared both the myofibroblast content and the ECM
remodeling capacity of ASCs isolated from adipose tissue (Fig. 2A).
Only a small quantity of ASCs can be isolated frommammary adipose
tissue, and differences inmammary fat were comparable to those presentwww.Sciencin inguinal (a mix of subcutaneous andmammary) depots (fig. S2, A to
C); thus, ASCs were isolated from the stromal vascular fraction of
inguinal adipose tissue from age-matched wild-type and ob/ob mice
(20.2 ± 1.4 g versus 56.6 ± 3.3 g; mean ± SD). Indeed, ASCs from obese
mice were enriched for a-SMA+myofibroblasts (Fig. 2B). Furthermore,
these cells also exhibited enhanced proliferative capacity (Fig. 2C) and
secreted more stromal cell–derived factor 1 (SDF-1) (Fig. 2D)—both
markers of myofibroblasts or activated fibroblasts (21, 22)—than their
lean counterparts. Finally, as compared to wild-type ASCs, ob/ob ASCs
assembled thicker ECMs enriched with collagen and fibronectin (Fig. 2,
E and F), further confirming the profibrotic phenotype of these cells.
Next, we verified that the above-described cellular changeswere uni-
versal rather than limited to the genetic makeup of ob/ob ASCs. We
performed experiments with ASCs isolated from the diet-induced mouse
model of obesity as well as ob/ob ASCs supplemented with leptin to at UC M
ERCED on April 28, 2020
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 Fig. 2. Obesity enhances the profibrotic phenotype of ASCs. (A) Sche-
matic showing ASC isolation from inguinal fat of age-matched lean and obese
Confocal analysis of collagen type I or fibronectin deposition by WT and
ob/ob ASCs. (F) Western blot quantification of fibronectin deposition rela-mice. (B) Immunofluorescence analysis of a-SMA+ ASCs isolated from ob/ob
relative to WT fat. Western blot analysis of a-SMA relative to b-actin. (C) Per-
centage of a-SMA+ and BrdU+ ASCs as analyzed by immunofluorescence.
(D) SDF-1 secretion of WT and ob/ob ASCs as determined by enzyme-
linked immunosorbent assay (ELISA) and normalized to DNA content. (E)etive to b-actin. (G) Comparison of ASCs isolated from low-fat diet– and
high-fat diet–fed mice for a-SMA levels and BrdU incorporation by immu-
nofluorescence; SDF-1 secretion by ELISA; and fibronectin matrix deposition
by confocal microscopy. Scale bars, 200 mm. (B to G) Data are means ± SD
(n = 3 to 6 per condition). P values by unpaired two-tailed t tests.TranslationalMedicine.org 19 August 2015 Vol 7 Issue 301 301ra130 3
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 reconstitute the leptin-mediated effects on cellular phenotype that are
independent from satiety regulation. ASCs isolated from inguinal fat of
mice fed a high-fat diet had elevated a-SMA levels, proliferative capacity,
SDF-1 secretion, andmatrix deposition, similar toASCs from ob/obmice
(Fig. 2G). Leptin supplementation did notmitigate the increased profibrotic
potential of ob/ob ASCs because neither a-SMA levels nor fibronectin
deposition significantly decreased with this treatment (fig. S3, A and B).
Collectively, these results suggest that obesity promotes ECM remodel-
ingby increasing themyofibroblast content of the adipose stromal vascular
fraction in both diet- and genetically induced mouse models of obesity,
regardless of ovary function. Thus, we performed all following
experiments with ob/ob ASCs.
Obesity-associated ASCs deposit partially unfolded and stiff ECMs
Given that myofibroblast-mediated changes of ECM composition and
structure can increase malignancy by changing microenvironmental
stiffness, we next tested whether the obesity-mediated effects on ASCs
translate to alteredECMmechanics.Although increased rigidity of fibrot-
ic and tumor tissue is typically believed to reflect alterations in collagen
synthesis and cross-linking (13), variations in the fibronectin matrix
structure and mechanics may be equally important. In fact, cellular dep-
osition and remodeling of fibronectin is critical to the formation andwww.Sciencturnover of collagen I–based ECMs (23), and both fibronectin conforma-
tional andmechanical changesmay play an important role in this process
(24, 25). Förster resonance energy transfer (FRET) analysis of fibronectin
conformation indicated that ASCs isolated from obese mice partially un-
fold fibronectin matrix fibers (Fig. 3, A and B) thereby mimicking fibro-
nectin changes mediated by tumor-associated ASCs (26).
Partial fibronectin unfolding may change cellular behavior not only
by exposing cryptic sites (27) or disrupting strain-sensitive binding sites,
such as the a5b1 integrin binding site (28), but also by directly elevating
fibronectin fiber rigidity (26). To confirm that obesity affects the rigidity of
ASC-deposited ECMs at the cellular/matrix level, we performed quasistatic
compressivemeasurements with the surface forces apparatus (SFA) (Fig. 3C)
(27). Our results verified that obesity elevates matrix rigidity (Fig. 3D), a
phenomenonassociatedwithmalignancy(8).Thedeterminedelasticmoduli
were relatively low compared with previously reported tumor stiffness (8),
given our specific sample preparation technique (measurements of decellu-
larized, nonfixedECMs immersed in saline).Nevertheless, they are relevant
because the stiffness of ECMs deposited by tumor-conditionedASCs un-
der the same experimental conditions was in a similar compliant range
and was increased relative to control ASCs (27). Lastly, analysis of in-
terstitial mechanics of breast tissue from wild-type and ob/ob mice with
atomic forcemicroscopy (AFM)nanoindentation further validated that the at UC M
ERCED on April 28, 2020
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ECMs. (A) FRET analysis of fibronectin conformation in ECMs deposited by
cylindrical discs; D0 and D are the undistorted and force-applied thicknesses
of the matrix, respectively. (D) Compressive elastic moduli of decellular-WT or ob/ob ASCs. Schematic shows separation of donor (Do) and acceptor
(Ac) fluorophores due to partial fibronectin unfolding. Pseudocolored im-
munofluorescence micrographs depict FRET intensities of fibronectin fibers
in the different ECMs. Scale bars, 50 mm. (B) Representative histogram of
FRET intensity distribution as analyzed from the fields of view shown in (A).
Box and whisker plots of FRET intensities as analyzed from six to eight rep-
resentative fields of view per condition. Data are medians with whiskers
from minimum to maximum values. (C) SFA indentation analysis of decellu-
larized ECMs between two silvered mica surfaces mounted on a cantilever
spring of constant k. F is normal force; R is the radius of curvature of theeized ECMs with corresponding fibronectin immunofluorescence micro-
graphs. Box plots show medians with whiskers from minimum to maximum
values from four random fields per condition. Scale bars, 100 mm. (E) AFM
analysis to assess the elastic moduli of interstitial mammary fat. (Left)
Picrosirius Red–stained histological cross sections showing representative
regions of analysis. (Middle) Representative force versus indentation curve.
(Right) Data are average compressive elastic moduli ± SD, analyzed from
four samples per condition (20 areas per sample). Scale bars, 100 mm. P values
in (B), (D), and (E) were determined by unpaired two-tailed t tests. PBS,
phosphate-buffered saline.TranslationalMedicine.org 19 August 2015 Vol 7 Issue 301 301ra130 4
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sequently, obesity affects the mechanical properties of the ECM
deposited by ASCs, which may ultimately lead to interstitial stiffening.
ASCs isolated from visceral fat of ob/ob mice similarly exhibited
enhanced profibrotic potential comparedwith those from thewild-type,
as detected by elevated a-SMA and fibronectin content and partial un-
folding of deposited fibronectin matrices (fig. S4, A to C). However, in
wild-type animals, visceral fat not only contained fewer a-SMA+ASCs
than inguinal fat (24.8 ± 2.4% versus 39.2 ± 16.2%; mean ± SD, n = 3
per group), but visceral fat–derived wild-type ASCs also deposited less
ECMcomparedwithwild-typeASCs from inguinal fat (fig. S4D). These
results suggest that obesitymay alter themechanical properties of adipose
interstitial tissue at varying anatomical depots, but that the extent of these
changes may be enhanced at inguinal relative to visceral sites.
ECM deposited by obesity-associated ASCs promote
myofibroblast differentiation via altered mechanosignaling
We next tested whether the changes in ECM physicochemical properties
directly contribute to the increased levels ofmyofibroblasts inobese adiposewww.Scienctissue (fig. S5A) because it has been shown that elevated ECM stiffness can
promote myofibroblast differentiation (29). Wild-type ASCs exhibited
enhanced a-SMA levels when cultured on decellularized matrices depo-
sited by ob/ob ASCs versus wild-type ASCs, whereas the wild-type ECMs
did not affect a-SMA protein expression in ob/ob ASCs (fig. S5B). The
presence of the Rho-associated protein kinase (ROCK) inhibitor Y27632
did not elevate a-SMA in wild-type ASCs cultured in ob/ob ECM, indi-
cating that ECM-induced differences were related to varied cell contrac-
tility and, thus,mechanotransduction. Inhibition of cell contractilitywith
Y27632 reduced a-SMA in ob/ob ASCs on both types of decellularized
ECM (fig. S5B), consistent with previous findings that contractility is
mandatory for maintenance of the myofibroblast phenotype (30).
The amount of endogenously sequesteredTGF-bwas similar in both
types of decellularized ECM (fig. S5C), and saturating TGF-b–binding
sites in the different ECMs (by incubation with exogenous TGF-b be-
fore cell seeding) had no significant effect on a-SMAprotein expression
(fig. S5D).Differentialmechanical activationof latent, ECM-sequestered
TGF-b (31) was not responsible for the myofibroblastic cell popula-
tion because we observed no marked difference in a-SMA levels wheneTranslationalMedicine.org 19
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 latency-associated peptide (LAP), a cellu-
lar force transmissionmolecule, was func-
tionally inhibited (fig. S5D). Collectively,
these findings suggest that the varied ECM
physicochemical properties of obese inter-
stitial adipose tissue provide a direct, TGF-
b–independentpositive feedbackmechanism
that elevatesmyofibroblast content in obese
adipose tissue.
Obesity-associated ASCs
stimulate breast cancer
mechanosensitive growth
Next, we examined the impact of obesity-
associated ECM remodeling on mammary
tumor cells by seeding MDA-MB231 hu-
man breast cancer cells onto decellularized
matrices assembled by age-matched wild-
type and ob/obASCs (Fig. 4A). In line with
the observation that ASC-derived myofi-
broblasts deposit ECMs that promote breast
cancer cell proliferation (11), MDA-MB231
growthwas significantly enhanced on ob/ob
ECMs (Fig. 4B). Given that ob/obASCs can
unfold fibronectin, which in turn can alter
cell behavior by modulating binding speci-
ficity of synergy-dependent (for example,
a5b1) and non–synergy-dependent (for
example, avb3) integrins (28, 32), we first
tested whether the detected differences in
tumor cell growth were due to fibronectin
conformation–dependent variations ina5b1
and avb3 engagement. Supplementation of
neither a5b1 nor avb3 function–blocking
antibodies significantly affected MDA-MB231
growth on wild-type or ob/obmatrices (fig.
S6A). These data indicate that fibronectin
conformational changes are not primarily
responsible for the differential tumor cellFig. 4. ECMs deposited by obesity-associated ASCs stimulate MDA-MB231 mechanosensitive
growth. (A) Experimental setup to analyze human breast cancer cell lineMDA-MB231 behavior in response
to decellularizedWT and ob/ob ECMs. (B) Number of MDA-MB231 cells after culture on decellularized ob/ob
orWT ECMs asdeterminedby image analysis. Scale bar, 100mm. (C) Immunofluorescence analysis of pFAK[397]+
MDA-MB231 (red arrows) after culture on the different ECMs and corresponding Western blot analysis of
pFAK[397] relative b-actin. Scale bars, 50 mm. (D) Immunofluorescence analysis of the nuclear/cytoplasmic
YAP/TAZ ratio ofMDA-MB231 after culture on ob/ob orWT ECMs. Scale bars, 50 mm (top); 20 mm (bottom).
P values in (B) to (D) determined by unpaired two-tailed t tests. (E) Effect of Y27632 on MDA-MB231 growth
on ob/ob or WT ECMs as assessed by image analysis of cell number. *P < 0.05 versus all other groups,
determined by two-way ANOVA. (B to E) Data are means ± SD (n = 3 per condition).August 2015 Vol 7 Issue 301 301ra130 5
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 response, leading us to investigate ECM-induced differences in tumor
cell mechanosignaling.
Increased stiffness stimulates tumor cell growth by alteringmechano-
transduction in a sequence of events, including enhanced RhoA/ROCK-
mediated cell contractility, phosphorylation of focal adhesion kinase
(pFAK), and ultimately YAP/TAZ transcription factor activity (33, 34).
We found that MDA-MB231 cells contained not only more pFAK
(Fig. 4C) but also more nuclear YAP/TAZ (Fig. 4D) when seeded onto
ECMs deposited by ob/ob compared with wild-type ASCs. Moreover,
inhibition of cell contractilitywith theROCK inhibitor Y27632 blocked
the growth-promoting effect of ECMs deposited by ob/obASCs (Fig. 4E),
which was paralleled by a reduction in pFAK (fig. S6B). These data
imply that obesity-induced interstitial ECM stiffness promotes tumor
cell growth by altering cell contractility–dependent signal transduction.
Obesity-associated differences in local interstitial stiffness are rele-
vant even to tumor cells not directly in contact with these sites, as the
increased levels of SDF-1 secreted by obese ASCs (Fig. 2D) stimulated
MDA-MB231 migration via the SDF-1/CXCR4 signaling axis as com-
pared to a similar number of lean ASCs (fig. S6C).
Obesity-associated ECMs promote the tumorigenic potential
of premalignant human breast epithelial cells
To assess whether the detected differences in obesity-associated ECM
remodeling also drive the transformation of premalignant cells, wewww.Sciencperformed experiments with premalignant MCF10AT human breast
epithelial cells (35). Indeed, ob/obASC–derived decellularized ECMs
promoted the growth of MCF10AT cells because of matrix-induced
changes in cell contractility as confirmed by blockade of Rho/ROCK
signaling with Y27632 (Fig. 5A).
Additionally, we tested the effect of the different matrices on the
disorganization of three-dimensional (3D) MCF10AT acini, a hallmark
of malignant transformation (8, 36). Structurally intact MCF10AT
mammary acini were seeded onto either wild-type or ob/ob ECMs
(Fig. 5B). Acini cultured on ob/ob matrices were significantly more dis-
organized relative to acini cultured on the corresponding wild-type
matrices (Fig. 5C). To confirm that these differences were not solely
due to changes of cell proliferation, we analyzed MCF10AT cell migra-
tion on the different ECMs. The ob/ob ECMs promoted the migration
of premalignant MCF10AT cells along ECM fibers (Fig. 5D, i) and away
from their original position (Fig. 5D, ii) more so than did wild-type
ECMs. Additionally, quantification of motility over the course of 5 hours
confirmed the increased migration speed of MCF10AT cells on ob/ob
ECMs (Fig. 5D, iii).
Obesity-associated ECM remodeling also occurs in human
breast tissues
To determine the clinical relevance of our findings in mice and in vitro
with human cell lines, we analyzed tumor-free breast tissue from nor-eTranslationalMedicine.org 19
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ag.org/mal, overweight, and obese patients. Spe-
cimens were derived from a previously
published cohort of patients undergoing
mastectomy (37) and were collected from
either the contralateral breast or fromparts
not involved by the tumor to ensure that
only noncancerous breast tissue was ana-
lyzed.a-SMAlevelswere increased inobese
humanbreast tissue (Fig. 6A), andSHGim-
aging indicateda corresponding increase in
collagen fiber aligned length (Fig. 6B).
Consistent with in vitro results (fig. S5),
a-SMA levels in these tissues did not cor-
relate with TGF-b expression, but did with
obesity-associated ECM remodeling such
as the amount of deposited fibronectin and
collagen fiber thickness; a trend, but no sta-
tistical significance was noted for collagen
fiber aligned length. In addition, a-SMA
levels positively correlated with inflamma-
tion [indicated by crown-like structure of
the breast (CLS-B) index] (Fig. 6C), confirm-
ing results from others that macrophage-
derived factors may in part contribute to
the increased levels of ECM remodeling
in obese mice (38). The integrated effects
of several obesity-associated parameters
may therefore be necessary to accurately
predict the risk of obesity-associated pro-
tumorigenic matrix remodeling.
Additionally, we analyzed desmoplas-
tic remodeling in breast cancer specimens
collected from lean and obese women.
Pathological scoring of H&E-stainedFig. 5. Obesity-associated ECMs promote the tumorigenic potential of premalignant human breast
epithelial cells. (A) Number of MCF10AT cells after culture on WT or ob/ob ECMs in the presence and ab-
sence of Y27632. Data are means ± SD (n = 3). *P < 0.05 versus all other groups, determined by two-way
ANOVA. Scale bars, 50 mm. (B) Methodology used to assess the effect of WT and ob/ob ECMs on the disor-
ganization of MCF10AT acini. Spreading was analyzed by measuring acini surface area and height. (C) Con-
focal image analysis of surface area and height of acini and representative confocal micrographs of intact
versus spread MCF10A acini (n = 100 acini per condition). Horizontal lines indicate means. Scale bar, 50 mm.
(D) Time-lapse imagingofMCF10ATmigrationonob/ob relative toWTECMs. (i) Representative image sequence
visualizing MCF10AT migration along fibronectin fibers. Scale bar, 20 mm. (ii) x-y coordinate maps tracking in-
dividual cells over 300min. (iii) ComputedMCF10ATmotility from (ii) (n=41 cells per condition). Horizontal lines
indicate means. P values in (C) and (D) determined by unpaired two-tailed t tests. FOV, field of view.August 2015 Vol 7 Issue 301 301ra130 6
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obese patients exhibited more severe desmoplasia relative to tumors
from lean patients (Fig. 7A, fig. S7, and table S1). Immunofluorescence
analysis confirmed increased levels of a-SMA+ cells and fibronectin in
samples from obese patients compared with lean ones (Fig. 7, B and C).
Moreover, obesity induces collagen-dependent structural changes that
likely contribute to enhanced mechanical rigidity because samples from
obese patients exhibited an increase not only in collagen fiber thickness
but also in fiber aligned length (Fig. 7D).
Lastly, we confirmed that the differential ECM properties of
obese human tumors correlated with enhanced mechanotransduction.
In agreement with our in vitro results (Fig. 4D), the epithelial compart-
ment of tumors from obese patients not only exhibited elevated overall
levels of YAP/TAZ but also greater nuclear accumulation relative to
tumors from lean patients (Fig. 7E). The detected changes in obesity-
associated ECM remodeling may thus correspond to elevated mechano-
signaling in obese tumors and play a key role in the worse clinical
prognosis of obese cancer patients (18).
In a larger cohort, we performed bioinformatic analysis of genes dif-
ferentially expressed in estrogen receptor–positive (ER+) breast cancerwww.Sciencin obese and nonobese patients (39). Consistent with our findings that
obesity promotes ECM-dependentmechanotransduction, which corre-
lates with inflammation, we found that obesity leads to enrichment of
functional pathways associated with ECM-, adhesion-, and inflammation-
related gene signatures in breast cancer patients (table S2). Further analysis
of these obesity-associated, ECM-related (n = 49), and inflammation-
related (n = 13) genes revealed a subset of eight genes common to both
pathways (Fig. 7F). These eight genes were checked for coexpression
with the other ECM-specific genes that were not common to the
ECM- and inflammation-related subset, to understand their interaction
with the other genes in the ECM pathway. This analysis indicates a
strong correlation between ECM- and inflammation-related genes in
obese ER+ breast cancer patients showing that the eight genes were sig-
nificantly coexpressed with other ECM-related genes [false discovery
rate (FDR) < 0.2]. Moreover, expression of two YAP/TAZ-regulated
genes (CTGF and ANKRD) (34), identified from a previously de-
scribed ECM density–based gene signature (7), were correlated signif-
icantly (FDR < 0.2) with a subset of these eight genes, suggesting a
possible co-regulation between obesity, mechanotransduction, ECM,
and inflammation in ER+ breast cancer patients (tables S2 and S3).eTranslationalMedicine.org 19 A
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fibrotic features in mammary
fat of obese mice
The therapeutic value of elective weight
loss is unresolved at both the clinical and
physiological levels, including the rever-
sal of adipose tissue interstitial fibrosis
(16, 40). Therefore, we tested whether
caloric restriction could reduce intersti-
tial fibrosis in mammary fat. Ovariecto-
mized mice were subjected to 10 weeks
of high-fat diet tomimic postmenopausal
obesity, followed by 7weeks of caloric re-
striction to suppress further weight gain,
according to our previous reports [22.1 ±
0.6 g (low-fat diet); 38.9 ± 2.2 g (high-fat
diet); 30.1 ± 0.8 g (high-fat diet/caloric
restriction)] (fig. S8A) (41). Caloric restric-
tion reduced the content of myofibro-
blasts in mammary fat interstitial tissue;
a similar, albeit not significant, trend was
noted for fibronectin (fig. S8, B and C).
These data suggest that caloric restriction
can reverse features of fibrotic remodel-
ing in mammary adipose tissue. Howev-
er, longer-term follow-up will be required
todeterminewhether thesecellular changes
translate to differences in ECM physico-
chemical properties and to extend this to
clinical specimens.DISCUSSION
Our results demonstrate that obesity leads
to the formation of mechanical niches in
adipose tissue that mimic characteristics ofFig. 6. Obesity-associated, tumor-free human breast tissue displays profibrotic features. (A and B)
Immunofluorescence analysis of a-SMA levels (A) and SHG image analysis of collagen fibers (B) in tumor-
freebreast tissue fromnormal, overweight, andobesewomen.Scalebar, 100mm(A); 50mm(B).Dataaremedians
with minimum and maximum values from 9 to 11 samples per group. P values by one-way ANOVA. (C) Corre-
lation of a-SMA levels with fibronectin levels (determined by immunofluorescence), collagen fiber thickness and
length (analyzed by SHG), TGF-b expression (measured by quantitative reverse transcriptase polymerase
chain reaction), and obesity-associated chronic inflammation (as defined by CLS-B index). Spearman’s rank
correlationwas used to determine P values, and its coefficient was denoted as rho (r). Data points represent
individual samples (n = 28).ugust 2015 Vol 7 Issue 301 301ra130 7
R E S EARCH ART I C L Etumor-associated stroma and promote carcinogenesis by altering
mechanotransduction. More specifically, obesity increases the number
of myofibroblasts in mammary adipose tissue, which, in turn, deposit
a more fibrillar, partially unfolded, and stiffer ECM. This altered ECM
not only provides a positive feedback mechanism for further myofi-
broblast differentiation but can also increase the malignant behavior
of mammary epithelial cells. Collectively, our results suggest that altered
ECM physicochemical properties not only are a hallmark of already
established tumors but may also be responsible for the increased riskwww.Sciencand worse clinical prognosis of obese breast cancer patients. The de-
tected changes in obesity-associated ECM remodeling correlated with
inflammation, a known hallmark of both tumorigenesis and obesity
(3, 42). Hence, our findings provide a new perspective on the tumor-
promoting capability of inflammation (2).
Although obesity induces fibrosis in subcutaneous and visceral adi-
pose tissue (16), our results show that similar changes also occur inmam-
mary adipose tissue. This observation is important given that (i) the global
functions and fibrotic remodeling of adipose tissue vary between ana-eTranslationalMedicine.org 19
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 tomic depots (4, 16) and (ii) the local mi-
croenvironmentof thebreast is indisputably
relevant tomammary tumorigenesis (43).
Obesity also caused fibrotic remodeling
in mammary fat from ovariectomized
mice, further suggesting that obesity-
associated stiffening of the ECM occurs
independently of hormone status and is
therefore pertinent to both pre- and post-
menopausal breast cancers. The levels
of obesity-associated fibrotic remodeling
were the same in control and ovariecto-
mized mice, although the latter featured
increased bodyweight and inflammation
(19). Hence, it is possible that a threshold
for inflammation-mediated fibrotic changes
exists. Nevertheless, it is also conceivable
that ovariectomy counterbalances some
of the profibrotic effects mediated by
obesity/inflammation because reduced
estrogen levels can diminish fibrosis (44).
The described obesity-associated changes
in ECM physicochemical characteristics
were related to an increase of myofibro-
blasts (11), which elevated matrix stiff-
ness consistent with previous reports, for
instance, by increasing ECM quantity (8),
collagen alignment (45), and fibronectin
unfolding (27). Obesity-associated ECMs
elevated ASC contractility and thus myo-
fibroblast differentiation, a mechanism
also reported for cancer-associated fibro-
blasts (30). Nevertheless, increased myo-
fibroblast content in obese breast tissue
may also arise from alternative mecha-
nisms including increased recruitment of
bone marrow mesenchymal cells (46) or
altered adipocyte-macrophage crosstalk
(38). In addition to changing ASC behav-
ior, obesity-associated ECMs increased
the malignant behavior of MDA-MB231
and premalignantMCF10AThuman breast
cancer cells. Hence, obesity-associated
changes in breast adipose tissue intersti-
tial stiffness not only promote aggres-
sion of already existing tumors but
may also contribute to the transforma-
tion of early-stage breast cancer. This
is particularly relevant because obeseFig. 7. Obesity-associated ECM remodeling in patient samples. (A) Histopathological scoring of
clinical tumor specimens for degree (1 to 3) of desmoplasia (n = 17 to 18 patients per group). Scale
bars, 200 mm. Statistical significance was assessed by Fisher’s exact test. (B and C) Immunofluorescence
analysis of a-SMA (B) and fibronectin (C) content in breast tumor specimens from obese and lean pa-
tients (n = 10 patients per group). (D) SHG image analysis of collagen fiber thickness and length. Data are
medians with minimum and maximum values (n = 10 patients per group). P values in (B to D) were
determined by Mann-Whitney U tests. (E) Immunofluorescence image analysis of epithelial total and nuclear
YAP/TAZ in tumors. Data points are individual images (n =10 images per patient, 10 patients per group).
P values bymixed-model design ANOVA. Scale bars, 100 mm. (F) Bioinformatics analysis of published data (39)
to correlate obesity-induced transcriptomic changes with ECM- and inflammation-related gene signatures.August 2015 Vol 7 Issue 301 301ra130 8
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 ASCs secrete enhanced levels of SDF-1–stimulating cellular recruitment
to sites of protumorigenic ECM remodeling. However, whether dif-
ferent tumor subtypes may vary in their responsiveness to obesity-
associated ECM changes should be confirmed with primary cells and
patient samples stratified by tumor subtype.
Using specimens from lean and obese patients as well as testing the
effect of caloric restriction on fibrotic remodeling of mammary fat, we
provide experimental evidence supporting the clinical relevance of our
results. We demonstrated not only that obesity promotes features of fi-
brotic remodeling in cancer-free breast tissue but also that obesity
worsens desmoplasia and the related ECMchanges inmammary tumors.
Weight loss and exercise are routinely recommended for obese cancer
patients because this regime may improve the clinical outcome of
cancer patients (47). A number of possibilities including altered me-
tabolism (48) and reduction of local inflammation may contribute to
this end (41). Additionally, our data in obese, ovariectomized mice
suggest that caloric restriction can reverse fibrotic remodeling; a simi-
lar trend was noted for ECM remodeling, although the effect may be
delayed relative to cellular changes (49). Furthermore, the length of
exposure to altered ECM physicochemical properties may influence
the capability of ASC-derived myofibroblasts to lose their contractile
phenotype in response to dietary intervention (29).
On the basis of our reported results, a number of questions arise. The
initial obesity-associatedmechanisms elevating ECMmechanics are yet
unknown. Obesity-associated hypoxia may be responsible, given its
ability to up-regulate collagen cross-linking and, thus, ECM stiffness
(13, 50). Alternatively, obesity-associated chronic inflammation may
play a role. However, whether inflammation is the driver or rather a
consequence of ECM remodeling remains to be confirmed. Our patient
genetic data suggest a connection between obesity, ECM remodeling,
inflammation, and mechanotransduction, but more patients will be
necessary to discern the strength of this connection and whether in-
flammation contributes to increased stiffness of obese mammary fat
and tumors. Moreover, obesity-associated fibrosis has been corre-
lated with elevated levels of collagen type VI and its cleavage product,
endotrophin (4). Whether the tumor-promoting effects of these
factors may in part be related to altered ECM mechanics is unclear.
Although we evaluated the direct effect of obesity-mediated ECM
differences on ASCs and tumor cells, altered ECM mechanics can
indirectly promote tumorigenesis, for instance, by influencing solu-
ble factor (for example, adipokines) signaling and other stromal cell
responses (2, 27, 33).
Other than caloric restriction, there are several clinically relevant as-
pects to our study.Mammography is commonly used for early detection
of breast cancer and overall risk assessment because womenwithmam-
mographically dense breasts have a higher probability of developing
breast cancer. However, because fat is radiolucent, obese women appear
to havenondense breast tissue (51), althoughour data suggest that local,
microscale density changes still occur. Therefore, alternative high-
resolution imaging will be necessary to better localize and monitor
regions that may stimulate tumorigenesis in obese patients. Further-
more, adipose tissue or ASCs are increasingly being considered for re-
generative approaches to mastectomy. Thus far, little attention has
been given to the body habitus of the patient from whom the ASCs
are isolated, yet our data imply that ASCs from obese individuals
might promote recurrence of breast cancer relative to ASCs from lean
patients. Stratification of patients on the basis of obesity-associated
features may help to better assess the potential risk, if any, associatedwww.Sciencwith adipose tissue–based reconstructive approaches (52). Together,
our results are of broad relevance to the field of obesity-induced
cancer and inform a multitude of future opportunities in the arena
of physical sciences in oncology.MATERIALS AND METHODS
Study design
This study was designed to investigate the hypothesis that obesity-
associated fibrosis promotes breast cancer malignancy by altering
mechanotransduction. In vitro and in vivo experimentswere performed
to analyze obesity-associated ECM physicochemical properties. Tumor
cell responses to lean and obese ECMs were tested in vitro and con-
firmed with patient samples. All clinical samples were obtained from
patients with varying demographic background and were stratified on
the basis of body mass index. Sample sizes for analysis of mouse and
cancer-free human samples were based on our previous studies (37).
Sample sizes for analysis of clinical tumor sampleswere chosen to detect
a statistical significance of P < 0.05. For all in vitro studies, three
independent experiments with at least three samples per conditionwere
performed. Outliers were not excluded, but data from human breast tu-
mors were transformed by either log or square root before statistical
analysis. Histomorphometric analysis of mouse and patient samples
was blinded; in vitro experiments were not blinded.
Cell isolation and culture
ASCs were isolated from the stromal vascular fraction of either inguinal
(a mix of subcutaneous andmammary) or visceral white fat of both ge-
netic (11-week-old) and dietary (15-week-old) mouse models via colla-
genase digestion and density centrifugation (Fig. 2A) (53), as described
further in the Supplementary Methods.
Analysis of mammary tissue and cellular behavior
Differences in obesity-associatedbreast tissue remodeling and corresponding
changes in cellular behavior were assessed with cultured cells and ex vivo
mammary tissue by immunostaining, FRET and SHG image analysis,
Western blot, and SFA and AFM measurements as described in the
SupplementaryMethods. Ex vivomammary tissues (murinemammary
fat pads, tumor-free human breast tissue, and human breast tumor spec-
imens) were isolated as described in the Supplementary Methods.
Statistical analysis
Microsoft Excel, GraphPad Prism 5, and JMP 11 were used for statis-
tical analysis. Unless otherwise noted, unpaired Student’s t tests and
ANOVA with post hoc Tukey’s test were used to compare parametric
data between two conditions and among multiple conditions, respec-
tively. Results were also confirmed with the Mann-Whitney U test and
the Wilcoxon signed-rank test, respectively. Statistical correlation be-
tween the nonparametric variables of human breast tissue was assessed
by Spearman’s rank correlation, and its coefficient was denoted as
rho (r). The effect of obesity on human tumor samples (table S1) was
tested by Fisher’s exact test. Two-sided testing with normal-based 95%
confidence interval was performed for each analysis, and P < 0.05 was
considered statistically significant. In vitro results are shown for one
representative study after similar results were replicated in three
separate experiments. An independent statistician was consulted for
all statistical analyses.eTranslationalMedicine.org 19 August 2015 Vol 7 Issue 301 301ra130 9
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DSUPPLEMENTARY MATERIALS
www.sciencetranslationalmedicine.org/cgi/content/full/7/301/301ra130/DC1
Materials and Methods
Fig. S1. Obesity promotes interstitial fibrosis in breast adipose tissue after menopause.
Fig. S2. Inguinal depots of adipose tissue feature markers of interstitial fibrosis.
Fig. S3. The profibrotic potential of ob/ob ASCs is not due to leptin deficiency.
Fig. S4. Obesity-associated ASCs promote fibrotic ECM remodeling in visceral fat.
Fig. S5. ECMs deposited by obesity-associated ASCs promote myofibroblast differentiation.
Fig. S6. Physicochemical cues of ob/ob ECMs modulate MDA-MB231 behavior.
Fig. S7. H&E images of breast tumors with different subtypes.
Fig. S8. Caloric restriction decreases fibrosis in mammary fat of obese mice.
Fig. S9. Decellularized ECMs do not contain cellular residuals.
Table S1. Subtypes, demographics, and desmoplastic grade of lean and obese breast cancer
samples.
Table S2. Gene ontology data analysis.
Table S3. Correlation of YAP/TAZ-regulated genes with obesity-dependent ECM remodeling/
inflammation.
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mastectomy, as ASCs from obese individuals may have the capacity to promote breast cancer recurrence.
progression. However, a cautionary tale also exists in the use of adipose tissue and cells for patients after
behavior of fat cells and ECM mechanics, the authors point toward new drug targets for preventing cancer 
in mammary fat, suggesting a therapeutic angle for obesity-related cancers. By linking tumorigenesis to the
their lean counterparts. The authors further demonstrated that caloric restriction in obese mice decreased fibrosis 
thansevere fibrotic remodeling around tumors and higher levels of a key mechanosignaling component, YAP/TAZ, 
premalignant breast cells (those that have yet to become cancerous). Tissues from obese patients revealed more
mechanotransduction, ECM from obese mice promoted human breast cancer cell growth, as well as the growth of 
properties, via myofibroblasts and adipose stem cells (ASCs), regardless of ovary function. Through altered
fibrotic remodeling of the mammary fat pad, leading to changes in extracellular matrix (ECM) mechanical 
inducesand molecular changes that happen in breast tissue in obese animals and people. They found that obesity 
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